Evidence map›Paper›PMID 37066162›Full record

ArticlebioRxiv : the preprint server for biology2023

High-throughput colocalization pipeline quantifies efficacy of mitochondrial targeting signals across different protein types.

Sierra K Lear, Jose A Nunez, Seth L Shipman

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Sierra K LearGladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.
Jose A NunezDepartment of Mechanical Engineering, University of California, Santa Barbara, CA, USA.
Seth L ShipmanGladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.

Funding

Engineered Mitochondria for Therapeutic Donation and Mitochondrial Genome EditingDP2GM140917 · NIGMS · J. DAVID GLADSTONE INSTITUTES · PI SHIPMAN, SETH LAWLER · 2020 to 2020
$2.8M
RetroDecoys: Temporally-regulated and cell type selective technology for transcriptional controlR21EB031393 · NIBIB · J. DAVID GLADSTONE INSTITUTES · PI SHIPMAN, SETH LAWLER · 2022 to 2023
$520k
NIBIB NIH HHS R21 EB031393NIGMS NIH HHS DP2 GM140917
6 · The paper itself

Abstract

Efficient metabolic engineering and the development of mitochondrial therapeutics often rely upon the specific and strong import of foreign proteins into mitochondria. Fusing a protein to a mitochondria-bound signal peptide is a common method to localize proteins to mitochondria, but this strategy is not universally effective with particular proteins empirically failing to localize. To help overcome this barrier, this work develops a generalizable and open-source framework to design proteins for mitochondrial import and quantify their specific localization. By using a Python-based pipeline to quantitatively assess the colocalization of different proteins previously used for precise genome editing in a high-throughput manner, we reveal signal peptide-protein combinations that localize well in mitochondria and, more broadly, general trends about the overall reliability of commonly used mitochondrial targeting signals.

Identifiers

PMID37066162
PMCPMC10103990

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.